Nowack Rainer, Wiedemann Günther
Nephrology/Dialysis Centre Lindau, Friedrichshafener Str. 82, Lindau D-88131, Germany.
J Clin Apher. 2010;25(2):77-80. doi: 10.1002/jca.20228.
Pancytopenia with severe thrombocytopenia occurred in a patient treated with low-density lipoprotein (LDL)-apheresis by polyacrylate adsorption from whole blood, after treatment frequency had been increased from once to twice a week. Cell counts recovered with discontinuation of LDL-apheresis, but thrombocytopenia recurred after resumption of twice-weekly treatments. Thrombocyte counts remained stable following the replacement of polyacrylate adsorption from whole blood by double-filtration plasmapheresis. The complications' close coincidence with twice-weekly polyacrylate adsorption from whole blood suggests a causal relationship, although by a still unknown mechanism. Monitoring of thrombocytes should be advised in patients treated with LDL-apheresis by polyacrylate adsorption from whole blood.
一名通过从全血中用聚丙烯酸酯吸附进行低密度脂蛋白(LDL)单采治疗的患者,在治疗频率从每周一次增加到每周两次后,出现了全血细胞减少伴严重血小板减少的情况。停止LDL单采后细胞计数恢复,但恢复每周两次治疗后血小板减少复发。在用双重过滤血浆置换替代从全血中进行聚丙烯酸酯吸附后,血小板计数保持稳定。尽管机制尚不清楚,但这些并发症与每周两次从全血中进行聚丙烯酸酯吸附密切相关,提示存在因果关系。对于通过从全血中用聚丙烯酸酯吸附进行LDL单采治疗的患者,建议监测血小板。